FILE PHOTO: A computer image created by Nexu Science Communication together with Trinity College in Dublin, shows a model structurally representative of a betacoronavirus which is the type of virus linked to COVID-19, better known as the coronavirus linked to the Wuhan outbreak, shared with Reuters on February 18, 2020. NEXU Science Communication/via REUTERS
(Reuters) - U.S. health agencies, the European drug regulator and 16 top drugmakers will collaborate on vaccine and drug development efforts to fight the coronavirus pandemic, the U.S. National Institutes of Health said on Friday.
The partnership, known as the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), will focus on coordinating regulatory decisions and provide funding to move promising therapies into human trials.
Limited time offer:
Just RM5 per month.
